Sponsor Pipeline

Eva Morava-Kozicz Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05402345 A Study of GlcNAc on Tear Production in NGLY1-CDDG NGLY1 Deficiency Active, Not Recruiting
NCT05402332 Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801) PGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of Glycosylation Not Yet Recruiting
NCT05402384 AVTX-801 D-galactose Supplementation in SLC35A2-CDG SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation Not Yet Recruiting
Phase 1
NCT07572825 Assessing the Safety and Tolerability of NMN in DHDDS-CDG DHDDS-Congenital Disorder of Glycosylation Recruiting
Get alerts when Eva Morava-Kozicz's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free